Gene Therapy
43 Stories, most recent news story added Tue Dec 8, 7:13 pm ET
News Stories
-
Super Strength Substance Approaching Human Trials
Slashdot - Tue Dec 8, 7:13 pm ETkkleiner writes "You may remember Liam Hoekstra, the baby apparently born without the myostatin gene, and consequently sporting 40% more skeletal muscle than his peers. Using gene therapy, NCH scientists have been able to get follistatin (a myostatin blocker) to promote phenomenal muscle growth in macaque monkeys. NCH is now working with the FDA to perform the preliminary steps necessary for a ...
-
Judge tosses $1M investment lawsuit vs. erectile-dysfunction doctor
New York Daily News - Fri Dec 4, 9:12 pm ETSomething might be up, but it's not John Otto's bank account. The former patient of Dr. Arnold Melman, a world-renowned erectile dysfunction expert, says he lost $1 million investing in a gene therapy company recommended by the man-doc.
-
Penn Medicine News: Gene Therapy Hastens Healing Process in Chronic Leg Ulcers
University of Pennsylvania Health System - Wed Dec 2, 2:49 pm ETThe standard treatment for venous leg ulcers, lower limb compression, takes up to six months to heal and is unsuccessful in 30 -70 percent of cases. The new treatment involved injecting venous leg ulcers with a non-replicating adenovirus that expresses platelet-derived growth factor-β (PDGF-β).
-
Is Gene-Therapy Medical Treatment Ready for Prime Time?
Time Magazine - Fri Nov 27, 5:40 am ETAfter years of complications and high-profile setbacks, a series of small but intriguing advances has suggested that gene therapy may hold real future potential for treatment
-
AMT Announces Management Changes in Light of Refocused Strategy
redOrbit - Wed Dec 2, 2:09 am ETAMSTERDAM, December 2 /PRNewswire-FirstCall/ -- Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the field of human gene therapy, announced today a number of management changes.
-
Reportlinker Adds Gene Therapy - Worldwide Market Challenges & Opportunities
PR Newswire via Yahoo! Finance - Mon Nov 30, 9:07 am ETReportlinker.com announces that a new market research report is available in its catalogue:
-
Gamida Cell Announces Feasibility Study With Weill Cornell Medical College
PR Newswire via Yahoo! Finance - Wed Dec 2, 7:00 am ETGamida Cell announced today a feasibility study evaluating the preclinical safety and efficacy of a gene therapy product which combines technology from Weill Cornell Medical College and Gamida Cell.
-
Burnham Institute for Medical Research, Tavistock Group, Oregon Health and Science University Vaccine and Gene Therapy ...
GenomeWeb News - Sat Nov 28, 5:15 pm ETThe facility consists of a two-story administrative wing and a three-story research wing, set to seek certification from the US Green Building Council’s Leadership in Energy and Environmental Design or LEED program.
-
Salk technology leads to gene therapy success
Rancho Santa Fe Record - Thu Nov 19, 5:59 pm ETUsing a gene-therapy delivery system developed in the laboratory of Inder Verma at the Salk Institute for Biological Studies, an international research team successfully treated two boys from Spain suffering from adrenoleukodystrophy (ALD), the rare, inherited disease that was the focus of the Hollywood film "Lorenzo's Oil." The genetic disorder, in which the fatty insulation of nerve cells ...
-
Gene Increases Effectiveness Of Drugs Used To Fight Cancer, Allows Dosage Reduction
redOrbit - Tue Nov 24, 1:07 pm ETImage Caption: This image shows the effect of gene therapy combined with cytotoxic agents in E spheroids derived from breast cancer cell line MCF-7. A. Control; B. Doxorubicin 10nm, C. Paclitaxel 10nm, D. Docetaxel 10nm, combined with gene E. Credit: University of Granada
-
Gene increases effectiveness of drugs used to fight cancer and allows reduction in dosage
EurekAlert! - Tue Nov 24, 10:01 am ET( University of Granada ) The gene in question is a suicide gene, called "gene E," which leads to the death of tumor cells derived from breast, lung and colon cancer, and prevents their growth. Chemotherapy, radiotherapy and surgery show "limited" results in advanced stages of cancer, so the kind of gene therapy proposed by the scientists of the UGR is a huge breakthrough in cancer treatment.
-
Genes are now being used for healing
KVOA Tucson - Mon Nov 23, 11:12 am ETAround the world, there are more than 1,500 gene therapy trials going on to treat everything from Parkinson's to blindness to clogged arteries. Could the key to healing be in the body's building blocks?
-
Mount Sinai researchers to test first gene therapy For Alzheimer's patients
EurekAlert! - Tue Nov 17, 12:35 pm ET( The Mount Sinai Hospital / Mount Sinai School of Medicine ) Mount Sinai School of Medicine is one of 12 sites nationwide participating in the first Phase 2 clinical trial to test gene therapy treatment for Alzheimer's disease. The study is the first multicenter neurosurgical intervention in Alzheimer's research in the US.
-
Researchers to Test First Gene Therapy For Alzheimer's Patients
Newswise - Mon Nov 16, 12:57 pm ETResearchers are preparing for the first Phase 2 clinical trial to test gene therapy treatment for Alzheimer's disease. The study, the first multicenter neurosurgical intervention in Alzheimer's research in the U.S., utilizes a viral-based gene transfer system, CERE-110, that makes Nerve Growth Factor (NGF), a naturally occurring protein that helps maintain nerve cell survival in the brain.
-
Gene Therapy Brings New Muscle to Monkeys
MedicineNet.com - Fri Nov 13, 4:31 pm ETTitle: Gene Therapy Brings New Muscle to Monkeys Category: Health News Created: 11/12/2009 12:10:00 PM Last Editorial Review: 11/13/2009
Science Daily: Gene Therapy News
-
Gene therapy and stem cells save limb
Tue Dec 8, 8:00 pm EST -
Tiny RNA has big impact on lung cancer tumors
Tue Dec 8, 8:00 pm EST -
Tumor-attacking virus strikes with 'one-two punch'
Wed Dec 2, 11:00 am EST -
Discovery leads to effective treatment of painful skin condition
Fri Nov 27, 2:00 am EST -
Gene increases effectiveness of drugs used to fight cancer and allows reduction in dosage
Tue Nov 24, 12:00 am EST
